Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avadel Pharmaceuticals Plc ADR (AVDL)

Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 994,456
  • Shares Outstanding, K 96,362
  • Annual Sales, $ 27,960 K
  • Annual Income, $ -160,280 K
  • EBIT $ -64 M
  • EBITDA $ -62 M
  • 60-Month Beta 1.32
  • Price/Sales 34.46
  • Price/Cash Flow N/A
  • Price/Book 12.90

Options Overview Details

View History
  • Implied Volatility 58.05% ( +1.02%)
  • Historical Volatility 104.86%
  • IV Percentile 17%
  • IV Rank 31.36%
  • IV High 118.75% on 10/16/24
  • IV Low 30.31% on 06/12/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 836
  • Volume Avg (30-Day) 2,078
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 84,646
  • Open Int (30-Day) 71,836

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 6
  • High Estimate 0.03
  • Low Estimate -0.08
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +90.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.41 +13.92%
on 12/03/24
13.22 -18.91%
on 11/13/24
-2.43 (-18.48%)
since 11/12/24
3-Month
9.41 +13.92%
on 12/03/24
16.66 -35.65%
on 11/11/24
-3.22 (-23.13%)
since 09/12/24
52-Week
9.41 +13.92%
on 12/03/24
19.09 -43.84%
on 05/03/24
-3.67 (-25.50%)
since 12/12/23

Most Recent Stories

More News
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

AVDL : 10.74 (+4.07%)
Insider Purchase: Chief Executive Officer of $AVDL (AVDL) Buys 402 Shares

Gregory J Divis, the Chief Executive Officer of $AVDL ($AVDL), bought 402 shares of the company on 12-09-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

AVDL : 10.74 (+4.07%)
Insider Purchase: Director at $AVDL (AVDL) Buys 10,075 Shares

Geoffrey Michael Glass, a director at $AVDL ($AVDL), bought 10,075 shares of the company on 12-10-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

AVDL : 10.74 (+4.07%)
Insider Purchase: Director at $AVDL (AVDL) Buys 3,000 Shares

Linda Palczuk, a director at $AVDL ($AVDL), bought 3,000 shares of the company on 12-06-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

AVDL : 10.74 (+4.07%)
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

AVDL : 10.74 (+4.07%)
Avadel: Q3 Earnings Snapshot

Avadel: Q3 Earnings Snapshot

AVDL : 10.74 (+4.07%)
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

AVDL : 10.74 (+4.07%)
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

AVDL : 10.74 (+4.07%)
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

AVDL : 10.74 (+4.07%)
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

AVDL : 10.74 (+4.07%)

Business Summary

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates...

See More

Key Turning Points

3rd Resistance Point 11.47
2nd Resistance Point 11.23
1st Resistance Point 10.77
Last Price 10.74
1st Support Level 10.07
2nd Support Level 9.83
3rd Support Level 9.37

See More

52-Week High 19.09
Fibonacci 61.8% 15.39
Fibonacci 50% 14.25
Fibonacci 38.2% 13.11
Last Price 10.74
52-Week Low 9.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar